121 related articles for article (PubMed ID: 35014818)
1. C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using
Zhang X; Detering L; Sultan D; Heo GS; Luehmann H; Taylor S; Choksi A; Rubin JB; Liu Y
ACS Appl Bio Mater; 2022 Jan; 5(1):235-242. PubMed ID: 35014818
[TBL] [Abstract][Full Text] [Related]
2. Focused Ultrasound Enabled Trans-Blood Brain Barrier Delivery of Gold Nanoclusters: Effect of Surface Charges and Quantification Using Positron Emission Tomography.
Sultan D; Ye D; Heo GS; Zhang X; Luehmann H; Yue Y; Detering L; Komarov S; Taylor S; Tai YC; Rubin JB; Chen H; Liu Y
Small; 2018 Jul; 14(30):e1703115. PubMed ID: 29966035
[TBL] [Abstract][Full Text] [Related]
3. Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.
Zhao Y; Detering L; Sultan D; Cooper ML; You M; Cho S; Meier SL; Luehmann H; Sun G; Rettig M; Dehdashti F; Wooley KL; DiPersio JF; Liu Y
ACS Nano; 2016 Jun; 10(6):5959-70. PubMed ID: 27159079
[TBL] [Abstract][Full Text] [Related]
4. Focused ultrasound-enabled delivery of radiolabeled nanoclusters to the pons.
Ye D; Sultan D; Zhang X; Yue Y; Heo GS; Kothapalli SVVN; Luehmann H; Tai YC; Rubin JB; Liu Y; Chen H
J Control Release; 2018 Aug; 283():143-150. PubMed ID: 29864474
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall [(64)Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging.
Gao F; Cai P; Yang W; Xue J; Gao L; Liu R; Wang Y; Zhao Y; He X; Zhao L; Huang G; Wu F; Zhao Y; Chai Z; Gao X
ACS Nano; 2015 May; 9(5):4976-86. PubMed ID: 25919205
[TBL] [Abstract][Full Text] [Related]
6. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
[TBL] [Abstract][Full Text] [Related]
7. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
[TBL] [Abstract][Full Text] [Related]
8. Targeting VPAC1 Receptors for Imaging Glioblastoma.
Tripathi SK; Kean R; Bongiorno E; Hooper DC; Jin YY; Wickstrom E; McCue PA; Thakur ML
Mol Imaging Biol; 2020 Apr; 22(2):293-302. PubMed ID: 31292914
[TBL] [Abstract][Full Text] [Related]
9. Design of
Li Y; Zhao L; Xu X; Sun N; Qiao W; Xing Y; Shen M; Zhu M; Shi X; Zhao J
J Biomed Nanotechnol; 2019 Jun; 15(6):1201-1212. PubMed ID: 31072428
[TBL] [Abstract][Full Text] [Related]
10. Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (
Toussaint M; Deuther-Conrad W; Kranz M; Fischer S; Ludwig FA; Juratli TA; Patt M; Wünsch B; Schackert G; Sabri O; Brust P
Molecules; 2020 May; 25(9):. PubMed ID: 32384802
[TBL] [Abstract][Full Text] [Related]
11. Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.
Nisnboym M; Vincze SR; Xiong Z; Sneiderman CT; Raphael RA; Li B; Jaswal AP; Sever RE; Day KE; LaToche JD; Foley LM; Karimi H; Hitchens TK; Agnihotri S; Hu B; Rajasundaram D; Anderson CJ; Blumenthal DT; Pearce TM; Uttam S; Nedrow JR; Panigrahy A; Pollack IF; Lieberman FS; Drappatz J; Raphael I; Edwards WB; Kohanbash G
Cancer Res Commun; 2023 Jul; 3(7):1173-1188. PubMed ID: 37426447
[TBL] [Abstract][Full Text] [Related]
12. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme imaging: the role of nuclear medicine.
Alexiou GA; Tsiouris S; Voulgaris S; Kyritsis AP; Fotopoulos AD
Curr Radiopharm; 2012 Oct; 5(4):308-13. PubMed ID: 22642425
[TBL] [Abstract][Full Text] [Related]
14. Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.
Huang M; Xiong C; Lu W; Zhang R; Zhou M; Huang Q; Weinberg J; Li C
Mol Imaging Biol; 2014 Feb; 16(1):74-84. PubMed ID: 23918654
[TBL] [Abstract][Full Text] [Related]
15. PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.
Hu H; Huang P; Weiss OJ; Yan X; Yue X; Zhang MG; Tang Y; Nie L; Ma Y; Niu G; Wu K; Chen X
Biomaterials; 2014 Dec; 35(37):9868-9876. PubMed ID: 25224367
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of
Zheng B; Wu Q; Jiang Y; Hou M; Zhang P; Liu M; Zhang L; Li B; Zhang C
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112291. PubMed ID: 34474842
[TBL] [Abstract][Full Text] [Related]
18. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
19. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
20. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]